The impact of modern treatment principles may have eliminated lithium-induced renal failure
- PMID: 24346809
- DOI: 10.1177/0269881113516202
The impact of modern treatment principles may have eliminated lithium-induced renal failure
Abstract
We have previously shown that lithium can cause end-stage renal disease (ESRD): however, this serious side-effect of lithium in prophylactic treatment of mood disorders may reflect the treatment regime of the 1960s and 1970s. Today's modern treatment routines, intended to reduce or eliminate lithium-induced ESRD (Li-ESRD), were introduced in Sweden in the early 1980s. The aim of the present study was to test the hypothesis that these routines have eliminated the risk of Li-ESRD. We used the Swedish Renal Registry to identify patients on renal replacement therapy (RRT), treated with dialysis or renal transplantation, with suspected Li-ESRD in two regions of Sweden with altogether about three million inhabitants. We reviewed their medical records to verify the exposure to lithium treatment, the diagnosis of Li-ESRD and the date of starting the lithium treatment. We found 32 RRT patients in whom lithium treatment was the sole or main contributing cause of ESRD. The starting year of their lithium treatment was between 1965-1980 in all patients. No patient started lithium treatment later than 1980. Modern lithium treatment may have eliminated the risk of Li-ESRD. Our findings support the continued use of lithium as a safe drug for the long-term treatment of mood disorders.
Keywords: Affective disorders; adverse effects; chronic kidney failure; lithium.
Comment in
-
Response to "The impact of modern treatment principles may have eliminated lithium-induced renal failure" Aiff et al. 2014.J Psychopharmacol. 2014 Dec;28(12):1189-90. doi: 10.1177/0269881114552716. J Psychopharmacol. 2014. PMID: 25392462 No abstract available.
-
Reply to letter to the editor.J Psychopharmacol. 2014 Dec;28(12):1190. doi: 10.1177/0269881114553153. J Psychopharmacol. 2014. PMID: 25392463 No abstract available.
Similar articles
-
End-stage renal disease associated with prophylactic lithium treatment.Eur Neuropsychopharmacol. 2014 Apr;24(4):540-4. doi: 10.1016/j.euroneuro.2014.01.002. Epub 2014 Jan 17. Eur Neuropsychopharmacol. 2014. PMID: 24503277
-
Renal failure occurs in chronic lithium treatment but is uncommon.Kidney Int. 2010 Feb;77(3):219-24. doi: 10.1038/ki.2009.433. Epub 2009 Nov 25. Kidney Int. 2010. PMID: 19940841
-
Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.Nephrol Dial Transplant. 2010 Apr;25(4):1200-6. doi: 10.1093/ndt/gfp679. Epub 2009 Dec 27. Nephrol Dial Transplant. 2010. PMID: 20037169
-
[Chronic renal function disorders during lithium use].Ned Tijdschr Geneeskd. 2006 Aug 5;150(31):1715-8. Ned Tijdschr Geneeskd. 2006. PMID: 16924942 Review. Dutch.
-
[The effect of long-term lithium treatment on kidney function].Psychiatr Pol. 2012 Jul-Aug;46(4):627-36. Psychiatr Pol. 2012. PMID: 23214164 Review. Polish.
Cited by
-
Absolute and Relative Risks of Kidney Outcomes Associated With Lithium vs Valproate Use in Sweden.JAMA Netw Open. 2023 Jul 3;6(7):e2322056. doi: 10.1001/jamanetworkopen.2023.22056. JAMA Netw Open. 2023. PMID: 37418264 Free PMC article.
-
Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification.BMC Nephrol. 2018 Nov 3;19(1):305. doi: 10.1186/s12882-018-1101-4. BMC Nephrol. 2018. PMID: 30390660 Free PMC article. Review.
-
Lithium nephrotoxicity.Int J Bipolar Disord. 2015 Dec;3(1):28. doi: 10.1186/s40345-015-0028-y. Epub 2015 Jun 5. Int J Bipolar Disord. 2015. PMID: 26043842 Free PMC article.
-
Psychotropic Drugs and Adverse Kidney Effects: A Systematic Review of the Past Decade of Research.CNS Drugs. 2022 Oct;36(10):1049-1077. doi: 10.1007/s40263-022-00952-y. Epub 2022 Sep 26. CNS Drugs. 2022. PMID: 36161425
-
Safety and Efficacy of Combined Low-Dose Lithium and Low-Dose Aspirin: A Pharmacological and Behavioral Proof-of-Concept Study in Rats.Pharmaceutics. 2021 Nov 1;13(11):1827. doi: 10.3390/pharmaceutics13111827. Pharmaceutics. 2021. PMID: 34834241 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical